ASGN vs PLUS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ASGN exhibits strong financial health with a Piotroski F-Score of 7/9, indicating solid operational and balance sheet fundamentals. The company trades near fair value based on the Graham Number of $52.86, with a current price of $51.04, while forward P/E of 10.26 suggests discounted earnings expectations. Despite healthy margins and a strong balance sheet (Current Ratio 1.99, Debt/Equity 0.68), revenue and earnings are contracting YoY (-1.90% and -17.90% respectively), offsetting valuation appeal. Analysts concur with a 'hold' rating and target price of $51.17, aligning closely with current levels.
The company presents a stark dichotomy between strong growth and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 2/9. While the stock is attractively valued with a PEG ratio of 0.82 and trades well below its growth-based intrinsic value of $165.2, the deterministic health markers and bearish technical trend suggest underlying instability. Strong revenue and earnings growth are currently offsetting these risks, but the low F-Score indicates a need for caution regarding cash flow or operational efficiency.
Compare Another Pair
Related Comparisons
ASGN vs PLUS: Head-to-Head Comparison
This page compares ASGN Incorporated (ASGN) and ePlus inc. (PLUS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.